Abstract
Albendazole is a potent benzimidazole anthelmintic used in the treatment of human intestinal helmintiasis as well as of hydatid cysts and neurocysticercosis. Two analytical methods were standardized for determination of albendazole in pharmaceutical preparations (oral suspension), one by UV direct spectrophotometry at 230 nm usingas solvent 2% sulfuric acid in methanol, and another by HPLC using a Nucleosil® C18 (5μ−4.6×150 mm) Phenomenex® column, and a mobile phase consistingof methanol : 0.05M phosphate buffer (70:30; v/v), UV detection at 254nm and ambient temperature. The methods were applied to simulated and commercially available samples and the results were statistically compared showingthat both methods were accurate and sensitive and there was no significant difference between them.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
